Drug Database
VA

varicella zoster vaccine

✓ Approved

HK inno.N · 疫苗 · 疫苗

什么是 varicella zoster vaccine?

varicella zoster vaccine 是一种疫苗,由HK inno.N研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)。

药物档案

公司HK inno.N
药物类别疫苗, 大分子
给药途径Injectable (Others)
状态Approved

治疗适应症

varicella zoster vaccine 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsVaricella zoster virus infection✓ Approved

相关研究文献

PubMedInfection and drug resistance2026-11-17

Clinical Characteristics and Interpretive Challenges of CSF Varicella-Zoster Virus Detection by Metagenomic Next-Generation Sequencing: A Retrospective Case Series.

Wei Yan Y, Wang Xuyi X, Yu Weitong W, Zhao Chenxi C et al.

Varicella-zoster virus (VZV) may cause heterogeneous central nervous system (CNS) manifestations, often without a typical herpes zoster rash. Metagenomic next-generation sequencing (mNGS) enables broad pathogen detection in cerebrospinal fluid (CSF), but VZV reads may be difficult to interpret when additional microorganisms are detected or confirmatory testing is incomplete. This study described the clinical characteristics and interpretive challenges of patients with suspected CNS infection in whom VZV was detected in CSF by mNGS. This retrospective descriptive case series included patients evaluated at The Second Qilu Hospital of Shandong University from January 2019 to December 2024. Among 278 patients with suspected CNS infection who underwent CSF mNGS, 23 met the prespecified operational inclusion criteria. Clinical, CSF, neuroimaging, microbiological, treatment, and short-term outcome data were reviewed. Detected microorganisms were interpreted through integrated clinical assessment rather than sequencing findings alone. No comparison group was included. VZV reads meeting the inclusion criteria were detected in 23 of 278 patients (8.3%). The median age was 44 years, and 15 patients (65.2%) were male. Clinical syndromes spanned encephalitis, meningitis, meningoencephalitis, encephalomyelitis, and myelitis. A herpes zoster-associated rash was present in 10 patients (43.5%). All patients had CSF leukocytosis with lymphocytic predominance, and 21 (91.3%) had elevated CSF protein. VZV-specific polymerase chain reaction was not performed. Qualitative CSF anti-VZV IgM and IgG testing was performed in six patients, of whom two had positive IgM results. Additional microorganisms were co-detected in six patients, including Epstein-Barr virus, low-abundance herpes simplex virus type 1, and Listeria monocytogenes. The median Karnofsky Performance Status score at discharge was 90 (interquartile range, 90-100), with three patients (13.0%) scoring below 90. VZV detection by CSF mNGS occurred across heterogeneous neurological presentations, sometimes alongside additional microorganisms. VZV reads alone cannot establish pathogen causality, and their clinical significance requires integrated assessment of the neurological syndrome, CSF findings, neuroimaging, conventional microbiological investigations, immune status, co-detected microorganisms, and clinical course. The findings are descriptive and do not establish the diagnostic accuracy of mNGS.

PMID 43042328
阅读全文 →
PubMedGeriatrie et psychologie neuropsychiatrie du vieillissement2026-11-17

[2026 vaccination schedule for adults aged 65 years and older: towards comprehensive vaccine-based prevention in older age].

Corroyer-Simovic Bénédicte B

The 2026 French vaccination schedule redefines geriatric prevention, extending its focus beyond the prevention of infectious diseases to the preservation of independence and functional health. Yet vaccination coverage in France remains inadequate. To address immunosenescence, the strategy prioritizes comprehensive protection against respiratory infections caused by influenza viruses, SARS-CoV-2, pneumococcus and respiratory syncytial virus (RSV). For influenza, guidelines recommend the preferential use of enhanced vaccines-either high-dose or adjuvanted formulations-to improve protection in older adults and reduce hospital admissions. Covid-19 boosters remain essential for this vulnerable population, with the adjuvanted recombinant protein vaccine Nuvaxovid® available alongside mRNA vaccines. Pneumococcal prevention is considerably simplified: a single dose of the 21-valent pneumococcal conjugate vaccine (PCV21, Capvaxive®) is recommended for all adults aged 65 years and older. This vaccine covers the serotypes responsible for 83.5% of invasive pneumococcal disease cases in France in 2024. RSV vaccination is indicated for adults aged 75 years and older and for those aged 65 years and older with cardiopulmonary comorbidities, providing protection against severe disease and reducing hospital admissions during winter. Beyond respiratory infections, vaccination against herpes zoster with the adjuvanted recombinant vaccine Shingrix® is recommended for all adults aged 65 years and older. Recent data associate this vaccination not only with the prevention of postherpetic neuralgia but also with a reduced risk of stroke. Tdap-IPV boosters remain essential in the context of recent pertussis epidemics and the persistent risk of tetanus in older adults. Vaccine coadministration is safe and should be offered to improve coverage and reduce the number of visits required. When vaccination records are unavailable, the priority is to proceed with vaccination rather than delay protection. This proactive, integrated approach aims to address inadequate vaccination coverage, reduce mortality and preserve independence in older adults.

PMID 43042679
阅读全文 →
PubMedGeriatrie et psychologie neuropsychiatrie du vieillissement2026-11-17

[Beyond infection prevention: The indirect benefits of vaccination in older adults].

Aïdoud Amal A

In older adults, an acute infection is not merely a transient episode: it can trigger a cascade of cardiovascular complications and cognitive and functional deterioration, potentially leading to a lasting loss of independence. This review examines the extent to which vaccination can prevent these downstream consequences, beyond preventing infection itself. The strongest evidence relates to influenza vaccination, which has been associated with a reduction in cardiovascular events in several high-risk populations. Evidence of benefits is also emerging for other vaccines used in older adults, particularly those targeting herpes zoster and respiratory syncytial virus, although the strength of the evidence varies. However, geriatric consequences of infection, such as delirium, functional decline, impaired quality of life, or changes in place of residence, are rarely assessed in vaccine trials. Assessing these trajectories alongside infection-related outcomes would provide a fuller understanding of what vaccination can preserve in older adults.

PMID 43042680
阅读全文 →
PubMedJournal of neurovirology2026-11-17

Mismatched findings on ancillary examinations in virus-associated acute encephalopathy and encephalitis: pathological mechanisms and clinical significance.

Xu Mengyuan M, Miao Wei W, Li Chunyan C, Wang Ying Y et al.

In this review, we group three mechanistically distinct categories of acute brain dysfunction after viral infection under the term "virus-associated acute encephalopathy and encephalitis": (1) viral encephalitis, caused by direct invasion and replication of neurotropic viruses in the central nervous system; (2) post-infectious autoimmune encephalitis, triggered by infection-induced central nervous system autoimmune responses; and (3) acute encephalopathy syndromes without direct central nervous system infection, resulting from systemic inflammatory storms or hypoxia. The three entities are grouped as a conceptual framework rather than an established classification because they all present as acute brain dysfunction occurring in association with viral infection and differ only in mechanism. The diagnosis of virus-associated acute encephalopathy and encephalitis relies mainly on ancillary examinations, including neuroimaging, cerebrospinal fluid analysis, and electroencephalography. In clinical practice, ancillary findings are frequently mismatched: some tests may be negative while others are positive, and results can evolve with the pathological mechanism and disease stage. Recognizing these mismatches can help clinicians identify the possible mechanism of central nervous system injury and avoid diagnostic and treatment delays, and guide further testing. In particular, empirical intravenous acyclovir should be started promptly when herpes simplex virus (HSV) or varicella-zoster virus (VZV) encephalitis is clinically suspected. This article reviews the mechanisms of virus-associated acute encephalopathy and encephalitis, and discusses the common causes of such mismatches and strategies to manage them; the proposed framework is hypothesis-generating and is not intended as a validated diagnostic algorithm.

PMID 43040177
阅读全文 →
PubMedCureus2026-11-17

Progesterone Dermatitis (Progestogen Hypersensitivity) Presenting as a Polymorphic Drug Eruption After Oral Norethisterone: A Case Report.

Singh Ishika I, Vatve Maneesha M

Progestogen hypersensitivity (PH) describes hypersensitivity reactions to endogenous progesterone, classically termed autoimmune progesterone dermatitis, or to exogenous progestogens. Non-cyclical presentations can be difficult to distinguish from other dermatoses. We describe a case of a 46-year-old woman who developed a widespread pruritic rash 52 days after starting oral norethisterone for heavy menstrual bleeding. The rash began on her arms and progressed to involve the trunk and legs, with papules, pustules, confluent erythema, and crusting. Purpuric, targetoid lesions later developed on her lower legs, followed by pompholyx-like vesicles on her palms and a periorbital eczematous rash. Her eosinophil count was 1.2×109/L (normal range: 0.02-0.50x109/L) and C-reactive protein 16 mg/L (normal range: <5 mg/L). She was afebrile, with no mucosal involvement and no evidence of hepatic or renal dysfunction at presentation. Herpes simplex and varicella-zoster PCR were negative. Skin biopsy showed acanthosis, parakeratosis, and spongiosis, with a dermal infiltrate of lymphocytes and eosinophils. The clinical differentials included a drug eruption, pustular folliculitis, atypical pityriasis rubra pilaris, and erythema multiforme. Norethisterone was stopped, and she was treated with potent topical corticosteroids and a six-week tapering course of oral prednisolone, starting at 30 mg daily. Her skin was largely clear about nine weeks after norethisterone was stopped, with no relapse to date. Discussion at the clinicopathological meeting concluded that this was a delayed-type hypersensitivity reaction to norethisterone, consistent with exogenous PH. She declined a progesterone challenge and was advised to avoid progestogen-containing hormone therapy. This case describes a polymorphic, non-cyclical presentation of PH caused by an oral synthetic progestogen. It may complicate future management of menopausal symptoms, as women with an intact uterus usually require a progestogen alongside estrogen therapy to protect the endometrium.

PMID 43042198
阅读全文 →
PubMedTurkish archives of pediatrics2026-11-17

Herpes Zoster Shortly After Dupilumab Initiation in an Adolescent with Atopic Dermatitis: A Case Report.

Güllüce Hüseyin H, Canıtez Oral Zeycan Z, Küçük Külice Güney G, Onkun Enes E et al.

PMID 43041036
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多varicella zoster vaccine